Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human proinsulin

EU orphan designation number: EU/3/08/612   
Active ingredient: Recombinant human proinsulin
Indication: Treatment of retinitis pigmentosa
Sponsor: ProRetina Therapeutics S.L.
Plaza Cein, 5, Despacho T5, 31110 Noáin (Navarra), España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2009 Orphan designation EMEA/OD/087/08 (2009)1053 of 11/02/2009
22/06/2010 Change of name and/or address of sponsor EMEA/OD/087/08